发明名称 Methods of treatment of histamine H-4 receptor-related pruritus
摘要 The methods disclosed herein relate to the treatment of histamine H-4—related pruritus, by administering a histamine H-4 receptor inverse agonist that selectively accumulates at the biophases of the disorders, specifically RS-norketotifen or a pharmaceutically acceptable salt thereof. Potentiated antipruritic activity by simultaneous inhibition of histamine H-1 receptors and histamine H-4 receptors are described.
申请公布号 US9138431(B2) 申请公布日期 2015.09.22
申请号 US201313960114 申请日期 2013.08.06
申请人 BRIDGE PHARMA, INC. 发明人 Aberg A. K. Gunnar;Ciofalo Vincent B.
分类号 A01N43/40;A61K31/445;A61K31/4535 主分类号 A01N43/40
代理机构 Cantor Colburn LLP 代理人 Cantor Colburn LLP
主权项 1. A method of treating a mammal with selective inverse histamine H-1 agonists, and wherein the histamine H-4 receptor-related pruritus is associated with a dermal disorder selected from autoimmune dermatitis, contact dermatitis, dermal scleroderma, folliculitis, an insect bite, melanoma, parasites, scabies, sunburn, warts, xerosis, moles, and idiopathic pruritus.
地址 Sarasota FL US